Centre Hospitalier Universitaire De Dijon

Gastrointestinal oncology

Clinical research includes colorectal cancer, rectal cancer, small bowel adenocarcinoma, and ampullary adenocarcinoma, with interest in neoadjuvant and adjuvant chemotherapy, ctDNA-guided treatment, and surgery-related cancer care. Studies also extend to advanced gastroenteropancreatic neuroendocrine carcinoma.

  • Colorectal cancer
  • Rectal cancer
  • Small bowel adenocarcinoma
  • Ampullary adenocarcinoma

The sponsor is active in perioperative and post-surgical oncology, including strategies linked to microsatellite instability and mismatch repair deficiency.

Endocrinology and metabolic disease

Research activity covers type 1 diabetes with double diabetes features, focusing on glycaemic control and metabolic management. The portfolio also includes rare familial polycythemia associated with an EPO gene mutation.

  • Type 1 diabetes
  • Double diabetes
  • Familial polycythemia
  • EPO gene mutation

These studies reflect interest in complex metabolic phenotypes and inherited haematologic conditions.

Ophthalmology

The sponsor funds trials in diabetic macular oedema and macular telangiectasia type 1, with attention to retinal thickness, visual outcomes, and intravitreal treatment options. Research also addresses resistant retinal disease in people with diabetes.

  • Diabetic macular oedema
  • Macular telangiectasia type 1
  • Retinal disease
  • Intravitreal therapy

Its ophthalmic work spans both diabetic and non-diabetic retinal disorders.

Rheumatology and inflammatory disease

Clinical studies include giant cell arteritis and treatment strategies involving tocilizumab and methotrexate. The portfolio also includes autoimmune hemolytic anemia and aspirin use in acute pneumonia.

  • Giant cell arteritis
  • Autoimmune hemolytic anemia
  • Inflammatory disease
  • Acute pneumonia

These trials show interest in immune-mediated disease control and complications of systemic inflammation.

Critical care, urology, and neurological disorders

Research extends to vasoplegic syndrome, norepinephrine-refractory vasoplegic shock, and perioperative haemodynamic management in cardiac surgery. Additional studies address recurrent urinary tract infections, neurogenic bladder, and rare neurological conditions including TBR1-related neurocognitive disorder and Megalencephaly-CApillary malformation Polymicrogyria syndrome.

  • Vasoplegic syndrome
  • Refractory vasoplegic shock
  • Neurogenic bladder
  • TBR1-related neurocognitive disorder

The sponsor also studies idiopathic pulmonary fibrosis, broadening its interest in severe respiratory disease.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Early Treatment with Argipressin (Arginine Vasopressin) in Adult Intensive Care Patients with Norepinephrine-Resistant Vasoplegic Shock

    Recruiting

    3 1 1
    Investigated diseases:
    France
  • Study on Lithium Carbonate for Patients with TBR1-Related Neurocognitive Disorder

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of Dostarlimab Combined with Short Course Radiotherapy for Locally Advanced Rectal Cancer Patients with Microsatellite Instability

    Recruiting

    2 1 1 1
    Investigated drugs:
    France
  • Study on Using Oxaliplatin, Fluorouracil, and Folinic Acid for Treating Stage II Colon Cancer in Patients with Positive Circulating Tumor DNA

    Recruiting

    3 1 1 1
    Investigated diseases:
    France
  • Study on E. coli Polysaccharide for Reducing Antibiotic Use in Patients with Neurogenic Bladder and Recurrent Urinary Tract Infections

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study Comparing mFOLFIRINOX and Capecitabine or Gemcitabine for Patients with Resected Ampullary Adenocarcinoma

    Recruiting

    3 1 1 1
    Investigated diseases:
    France